Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis-Reference-Cited by-同舟云学术

Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis

Published:2015-03-25 Issue:1-2 Volume:404 Page:103-112
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Perera Yasser,Pedroso Seidy,Borras-Hidalgo Orlando,Vázquez Dania M.,Miranda Jamilet,Villareal Adelaida,Falcón Viviana,Cruz Luis D.,Farinas Hernán G.,Perea Silvio E.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11010-015-2370-x.pdf

Reference45 articles.

1. Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6:493–505

2. Borer RA, Lehner CF, Eppenberger HM, Nigg EA (1989) Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379–390

3. Yun JP, Chew EC, Liew CT, Chan JY, Jin ML, Ding MX, Fai YH, Li HK, Liang XM, Wu QL (2003) Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. J Cell Biochem 90:1140–1148

4. Hingorani K, Szebeni A, Olson MOJ (2000) Mapping the functional domains of nucleolar protein B23. J Biol Chem 275:24451–24457

5. Murano TK, Okuwaki M, Hisaoka M, Nagata K (2008) Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity. Mol Cell Biol 28:3114–3126

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise;Molecular and Cellular Biochemistry;2022-09-17

2. CK2 and the Hallmarks of Cancer;Biomedicines;2022-08-16

3. CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition;Frontiers in Molecular Biosciences;2022-03-11

4. Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization;Scientific Reports;2020-09-07

5. Characterization of low-abundance species in the active pharmaceutical ingredient of CIGB-300: A clinical-grade anticancer synthetic peptide;Journal of Peptide Science;2018-04-20